|
1
|
Sinaii N, Cleary SD, Ballweg ML, Nieman LK
and Stratton P: High rates of autoimmune and endocrine disorders,
fibromyalgia, chronic fatigue syndrome and atopic diseases among
women with endometriosis: a survey analysis. Hum Reprod.
17:2715–2724. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kvaskoff M, Mu F, Terry KL, Harris HR,
Poole EM, Farland L and Missmer SA: Endometriosis: A high-risk
population for major chronic diseases? Hum Reprod Update.
21:500–516. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rafi U, Ahmad S, Bokhari SS, Iqbal MA, Zia
A, Khan MA and Roohi N: Association of inflammatory
markers/cytokines with cardiovascular risk manifestation in
patients with endometriosis. Mediators Inflamm.
2021(3425560)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Surrey ES, Soliman AM, Johnson SJ, Davis
M, Castelli-Haley J and Snabes MC: Risk of developing comorbidities
among women with endometriosis: A retrospective matched cohort
study. J Women's Health (Larchmt). 27:1114–1123. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shigesi N, Kvaskoff M, Kirtley S, Feng Q,
Fang H, Knight JC, Missmer SA, Rahmioglu N, Zondervan KT and Becker
CM: The association between endometriosis and autoimmune diseases:
A systematic review and meta-analysis. Hum Reprod Update.
25:486–503. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yin Z, Low HY, Chen BS, Huang KS, Zhang Y,
Wang YH, Ye Z and Wei JCC: Risk of ankylosing spondylitis in
patients with endometriosis: A population-based retrospective
cohort study. Front Immunol. 13(877942)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zervou MI, Vlachakis D, Papageorgiou L,
Eliopoulos E and Goulielmos GN: Increased risk of rheumatoid
arthritis in patients with endometriosis: Genetic aspects.
Rheumatology (Oxford). 61:4252–4262. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zervou MI, Papageorgiou L, Vlachakis D,
Spandidos DA, Eliopoulos E and Goulielmos GN: Genetic factors
involved in the co-occurrence of endometriosis with ankylosing
spondylitis (review). Mol Med Rep. 27(96)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zervou MI, Tarlatzis BC, Grimbizis GF,
Spandidos DA, Niewold TB and Goulielmos GN: Association of
endometriosis with Sjögren's syndrome: Genetic insights (review).
Int J Mol Med. 53(20)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
As-Sanie S, Mackenzie SC, Morrison L,
Schrepf A, Zondervan KT, Horne AW and Missmer SA: Endometriosis: A
review. JAMA. 334:64–78. 2025.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Symons LK, Miller JE, Kay VR, Marks RM,
Liblik K, Koti M and Tayade C: The immunopathophysiology of
endometriosis. Trends Mol Med. 24:748–762. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zondervan KT, Becker CM, Koga K, Missmer
SA, Taylor RN and Viganò P: Endometriosis. Nat Rev Dis Primers.
4(9)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Abramiuk M, Grywalska E, Małkowska P,
Sierawska O, Hrynkiewicz R and Niedźwiedzka-Rystwej P: The role of
the immune system in the development of endometriosis. Cells.
11(2028)2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Eisenberg VH, Zolti M and Soriano D: Is
there an association between autoimmunity and endometriosis?
Autoimmun Rev. 11:806–814. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lebovic DI, Mueller MD and Taylor RN:
Immunobiology of endometriosis. Fertil Steril. 75:1–10.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Matarese G, De Placido G, Nikas Y and
Alviggi C: Pathogenesis of endometriosis: Natural immunity
dysfunction or autoimmune disease? Trends Mol Med. 9:223–228.
2003.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Chen Z, Cui R, Wang SI, Zhang H, Chen M,
Wang Q, Tong Q, Wei JCC and Dai SM: Increased risk of subsequent
antiphospholipid syndrome in patients with endometriosis. Int J
Epidemiol. 54(dyae167)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Clark KEN and Giles I: Antiphospholipid
syndrome. Medicine. 46:118–125. 2018.
|
|
19
|
Sciascia S, Amigo MC, Roccatello D and
Khamashta M: Diagnosing antiphospholipid syndrome: ‘Extra-criteria’
manifestations and technical advances. Nat Rev Rheumatol.
13:548–560. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rodríguez-García V, Ioannou Y,
Fernández-Nebro A, Isenberg DA and Giles IP: Examining the
prevalence of non-criteria anti-phospholipid antibodies in patients
with anti-phospholipid syndrome: A systematic review. Rheumatology
(Oxford). 54:2042–2050. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Celia AI, Galli M, Mancuso S, Alessandri
C, Frati G, Sciarretta S and Conti F: Antiphospholipid syndrome:
Insights into molecular mechanisms and clinical manifestations. J
Clin Med. 13(4191)2024.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ravindran V, Rajendran S and Elias G:
Primary antiphospholipid syndrome in monozygotic twins. Lupus.
22:92–94. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lopez-Pedrera C, Barbarroja N,
Patiño-Trives AM, Collantes E, Aguirre MA and Perez-Sanchez C: New
biomarkers for atherothrombosis in antiphospholipid syndrome:
Genomics and epigenetics approaches. Front Immunol.
10(764)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zubrzycka A, Zubrzycki M, Perdas E and
Zubrzycka M: Genetic, epigenetic, and steroidogenic modulation
mechanisms in endometriosis. J Clin Med. 9(1309)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Barinotti A, Radin M, Cecchi I, Foddai SG,
Rubini E, Roccatello D, Sciascia S and Menegatti E: Genetic factors
in antiphospholipid syndrome: Preliminary experience with whole
exome sequencing. Int J Mol Sci. 21(9551)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gómez-Puerta JA and Cervera R: Diagnosis
and classification of the antiphospholipid syndrome. J Autoimmun.
48-49:20–25. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zervou MI, Matalliotakis M and Goulielmos
GN: Comment on ‘Risk of systemic lupus erythematosus in patients
with endometriosis: A nationwide population-based cohort study’.
Arch Gynecol Obstet. 305:543–544. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Goulielmos GN, Tarlatzi TB, Grimbizis GF,
Spandidos DA, Niewold TB, Bertsias G, Tarlatzis BC and Zervou MI:
Co-occurrence of endometriosis with psoriasis and psoriatic
arthritis: Genetic insights (review). Exp Ther Med.
30(171)2025.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Domenico Sebastiani G, Minisola G and
Galeazzi M: HLA class II alleles and genetic predisposition to the
antiphospholipid syndrome. Autoimmun Rev. 2:387–394.
2003.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ishii K, Takakuwa K, Kashima K, Tamura M
and Tanaka K: Associations between patients with endometriosis and
HLA class II; the analysis of HLA-DQB1 and HLA-DPB1 genotypes. Hum
Reprod. 18:985–989. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zong L, Pan D, Chen W, He Y, Liu Z, Lin J
and Xu A: Comparative study of HLA-DQA1 and HLA-DRB1 allele in
patients with endometriosis and adenomyosis. Zhonghua Yi Xue Yi
Chuan Xue Za Zhi. 19:49–51. 2002.PubMed/NCBI(In Chinese).
|
|
32
|
Bedaiwy MA, Falcone T and Casper RF:
Plasminogen activator inhibitor (PAI) and thrombin activatable
fibrinolysis inhibitor (TAFI) Polymorphisms in women with
endometriosis. Fertil Steril. 84 (Suppl 1):S189–S190. 2005.
|
|
33
|
Aisina RB, Mukhametova LI, Ostryakova EV,
Seredavkina NV, Patrushev LI, Patrusheva NL, Reshetnyak TM, Gulin
DA, Gershkovich KB, Nasonov EL and Varfolomeyev SD: Polymorphism of
the plasminogen activator inhibitor type 1 gene, plasminogen level
and thromboses in patients with the antiphospholipid syndrome.
Biochem Suppl Ser B Biomed Chem. 7:1–15. 2013.
|
|
34
|
Sayfutdinovich KZ, Shakarimovna AD,
Rudolfovna KT and Erkinovna ZN: Association of MTHFR and MTRR genes
with the development of antiphospholipid syndrome in pregnant women
of Uzbek population. Eur Sci Rev. 7-8:85–87. 2016.
|
|
35
|
Delli Carpini G, Giannella L, Di Giuseppe
J, Montik N, Montanari M, Fichera M, Crescenzi D, Marzocchini C,
Meccariello ML, Di Biase D, et al: Homozygous C677T
methylenetetrahydrofolate reductase (MTHFR) polymorphism as a risk
factor for endometriosis: A retrospective case-control study. Int J
Mol Sci. 24(15404)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Bianco B, Fernandes RFM, Trevisan CM,
Christofolini DM, Sanz-Lomana CM, de Bernabe JV and Barbosa CP:
Influence of STAT4 gene polymorphisms in the pathogenesis of
endometriosis. Ann Hum Genet. 83:249–255. 2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Horita T, Atsumi T, Yoshida N, Nakagawa H,
Kataoka H, Yasuda S and Koike T: STAT4 single nucleotide
polymorphism, rs7574865 G/T, as a risk for antiphospholipid
syndrome. Ann Rheum Dis. 68:1366–1367. 2009.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Latha M, Vaidya S, Movva S, Chava S,
Govindan S, Govatati S, Banoori M, Hasan Q and Kodati VL: Molecular
pathogenesis of endometriosis; Toll-like receptor-4 A896G (D299G)
polymorphism: A novel explanation. Genet Test Mol Biomarkers.
15:181–184. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pierangeli SS, Vega-Ostertag ME, Raschi E,
Liu X, Romay-Penabad Z, De Micheli V, Galli M, Moia M, Tincani A,
Borghi MO, et al: Toll-like receptor and antiphospholipid mediated
thrombosis: In vivo studies. Ann Rheum Dis. 66:1327–1333.
2007.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Carey BS, Poulton KV and Poles A: Factors
affecting HLA expression: A review. Int J Immunogenet. 46:307–320.
2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ali AM, Nader MI, Al-Ghurabi BH and
Mohammed AK: Association of HLA class II alleles (DRB1 and DQB1) in
Iraqi women with endometriosis. Iraqi J Biotechnol. 15:42–50.
2016.
|
|
42
|
Ioannidis JP, Tektonidou MG,
Vlachoyiannopoulos PG, Stavropoulos-Giokas C, Spyropoulou-Vlachou
M, Reveille JD, Arnett FC and Moutsopoulos HM: HLA associations of
anti-beta2 glycoprotein I response in a Greek cohort with
antiphospholipid syndrome and meta-analysis of four ethnic groups.
Hum Immunol. 60:1274–1280. 1999.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mansilha A, Araújo F, Severo M, Sampaio
SM, Toledo T, Henriques I and Albuquerque R: The association
between the 4G/5G polymorphism in the promoter of the plasminogen
activator inhibitor-1 gene and deep venous thrombosis in young
people. Phlebology. 20:48–52. 2005.
|
|
44
|
Dossenbach-Glaninger A, van Trotsenburg M,
Dossenbach M, Oberkanins C, Moritz A, Krugluger W, Huber J and
Hopmeier P: Plasminogen activator inhibitor 1 4G/5G polymorphism
and coagulation factor XIII Val34Leu polymorphism: Impaired
fibrinolysis and early pregnancy loss. Clin Chem. 49:1081–1086.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Islam MA, Khandker SS, Alam F, Kamal MA
and Gan SH: Genetic risk factors in thrombotic primary
antiphospholipid syndrome: A systematic review with bioinformatic
analyses. Autoimmun Rev. 17:226–243. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Raghubeer S and Matsha TE:
Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and
cardiovascular risks. Nutrients. 13(4562)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Guedes T, Santos AA, Vieira-Neto FH,
Bianco B, Barbosa CP and Christofolini DM: Folate metabolism
abnormalities in infertile patients with endometriosis. Biomark
Med. 16:549–557. 2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Luo Z, Lu Z, Muhammad C, Chen Y, Chen Q,
Zhang J and Song Y: Associations of the MTHFR rs1801133
polymorphism with coronary artery disease and lipid levels: A
systematic review and updated meta-analysis. Lipids Health Dis.
17(191)2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wu S, Wang M, Wang Y, Zhang M and He JQ:
Polymorphisms of the STAT4 gene in the pathogenesis of
tuberculosis. Biosci Rep. 38(BSR20180498)2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Korman BD, Kastner DL, Gregersen PK and
Remmers EF: STAT4: Genetics, mechanisms, and implications for
autoimmunity. Curr Allergy Asthma Rep. 8:398–403. 2008.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liang YL, Wu H, Shen X, Li PQ, Yang XQ,
Liang L, Tian WH, Zhang LF and Xie XD: Association of STAT4
rs7574865 polymorphism with autoimmune diseases: A meta-analysis.
Mol Biol Rep. 39:8873–8882. 2012.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Bravo-Villagra KM, Muñoz-Valle JF,
Baños-Hernández CJ, Cerpa-Cruz S, Navarro-Zarza JE, Parra-Rojas I,
Aguilar-Velázquez JA, García-Arellano S and López-Quintero A: STAT4
gene variant rs7574865 is associated with rheumatoid arthritis
activity and anti-CCP levels in the western but not in the southern
population of Mexico Mexico. Genes (Basel). 15(241)2024.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Podgaec S, Dias Junior JA, Chapron C, de
Oliveira RM, Baracat EC and Abrão MS: Th1 and Th2 ummune responses
related to pelvic endometriosis. Assoc Med Bras (1992). 56:92–98.
2010.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Medzhitov R and Janeway C Jr: Innate
immunity. N Engl J Med. 343:338–344. 2000.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Ozato K, Tsujimura H and Tamura T:
Toll-like receptor signaling and regulation of cytokine gene
expression in the immune system. BioTechniques. 33 (Suppl):S66–S75.
2002.PubMed/NCBI
|
|
56
|
Poltorak A, Smirnova I, He X, Liu MY, Van
Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, et al:
Genetic and physical mapping of the Lps locus: Identification of
the toll-4 receptor as a candidate gene in the critical region.
Blood Cells Mol Dis. 24:340–355. 1998.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Akira S, Uematsu S and Takeuchi O:
Pathogen recognition and innate immunity. Cell. 124:783–801.
2006.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Kim HJ, Kim H, Lee JH and Hwangbo C:
Toll-like receptor 4 (TLR4): New insight immune and aging. Immun
Ageing. 20(67)2023.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Yamakawa N, Ohto U, Akashi-Takamura S,
Takahashi K, Saitoh S, Tanimura N, Suganami T, Ogawa Y, Shibata T,
Shimizu T and Miyake K: Human TLR4 polymorphism D299G/T399I alters
TLR4/MD-2 conformation and response to a weak ligand monophosphoryl
lipid A. Int Immunol. 25:45–52. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Khan KN, Kitajima M, Fujishita A,
Nakashima M and Masuzaki H: Toll-like receptor system and
endometriosis. J Obstet Gynaecol Res. 39:1281–1292. 2013.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Anwar MA and Choi S: Structure-activity
relationship in TLR 4 mutations: Atomistic molecular dynamics
simulations and residue interaction network analysis. Sci Rep.
7(43807)2017.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Benhamou Y, Bellien J, Armengol G,
Brakenhielm E, Adriouch S, Iacob M, Remy-Jouet I, Le Cam-Duchez V,
Monteil C, Renet S, et al: Role of Toll-like receptors 2 and 4 in
mediating endothelial dysfunction and arterial remodeling in
primary arterial antiphospholipid syndrome. Arthritis Rheum.
66:3210–3220. 2014.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Palli E, Kravvariti E and Tektonidou MG:
Type I interferon signature in primary antiphospholipid syndrome:
Clinical and laboratory associations. Front Immunol.
10(487)2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tang KT, Chen HH, Chen TT, Bracci NR and
Lin CC: Dendritic cells and antiphospholipid syndrome: An updated
systematic review. Life (Basel). 11(801)2021.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Wu XG, Chen JJ, Zhou HL, Wu Y, Lin F, Shi
J, Wu HZ, Xiao HQ and Wang W: Identification and validation of the
signatures of infiltrating immune cells in the eutopic endometrium
endometria of women with endometriosis. Front Immunol.
12(671201)2021.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ahn SH, Khalaj K, Young SL, Lessey BA,
Koti M and Tayade C: Immune-inflammation gene signatures in
endometriosis patients. Fertil Steril. 106:1420–1431.e7.
2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Hubben AK, Bazeley P, Swaidani S, Alarabi
A, Kulkarni PP, Shim YJ, Palihati M, Barnard J and Mccrae KR:
Cytokine profiling in antiphospholipid syndrome demonstrates
persistent immune dysregulation and a procoagulant phenotype.
Blood. 142 (Suppl 1)(S5400)2023.
|
|
68
|
Yan H, Li B, Su R, Gao C, Li X and Wang C:
Preliminary study on the imbalance between Th17 and regulatory T
cells in antiphospholipid syndrome. Front Immunol.
13(873644)2022.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Llarena NC, Richards EG, Priyadarshini A,
Fletcher D, Bonfield T and Flyckt RL: Characterizing the
endometrial fluid cytokine profile in women with endometriosis. J
Assist Reprod Genet. 37:2999–3006. 2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Oală IE, Mitranovici MI, Chiorean DM,
Irimia T, Crișan AI, Melinte IM, Cotruș T, Tudorache V, Moraru L,
Moraru R, et al: Endometriosis and the Role of Pro-Inflammatory and
Anti-Inflammatory Cytokines in Pathophysiology: A narrative review
of the literature. Diagnostics (Basel). 14(312)2024.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Papageorgiou L, Andreou A, Zervou M,
Vlachakis D, Goulielmos GN and Eliopoulos E: A global population
genomic analysis shows novel insights into the genetic
characteristics of endometriosis. World Acad Sci J. 5(12)2023.
|
|
72
|
Goulielmos GN, Matalliotakis M,
Matalliotaki C, Eliopoulos E, Matalliotakis I and Zervou MI:
Endometriosis research in the-omics era. Gene.
741(144545)2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Zouein J, Naim N, Spencer DM and Ortel TL:
Genetic and genomic associations in antiphospholipid syndrome: A
systematic review. Autoimmun Rev. 24(103712)2025.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Murrin O, Mounier N, Voller B, Tata L,
Gallego-Moll C, Roso-Llorach A, Carrasco-Ribelles LA, Fox C, Allan
LM, Woodward RM, et al: A systematic analysis of the contribution
of genetics to multimorbidity and comparisons with primary care
data. EBioMedicine. 113(105584)2025.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Remmers EF, Plenge RM, Lee AT, Graham RR,
Hom G, Behrens TW, de Bakker PIW, Le JM, Lee HS, Batliwalla F, et
al: STAT4 and the risk of rheumatoid arthritis and systemic lupus
erythematosus. N Engl J Med. 357:977–986. 2007.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Zhou HY and Yuan M: MTHFR polymorphisms
(rs1801133) and systemic lupus erythematosus risk: A meta-analysis.
Medicine (Baltimore). 99(e22614)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Chen L, Huang Z, Liao Y, Yang B and Zhang
J: Association between tumor necrosis factor polymorphisms and
rheumatoid arthritis as well as systemic lupus erythematosus: A
meta-analysis. Braz J Med Biol Res. 52(e7927)2019.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Zervou MI and Goulielmos GN: Comment on:
Enhancing current guidance for psoriatic arthritis and its
comorbidities: Recommendations from an expert consensus panel.
Rheumatology (Oxford). 64:904–905. 2025.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Uthman I and Khamashta M: Ethnic and
geographical variation in antiphospholipid (Hughes) syndrome. Ann
Rheum Dis. 64:1671–1676. 2005.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Weeding E, Coit P, Yalavarthi S, Kaplan
MJ, Knight JS and Sawalha AH: Genome-wide DNA methylation analysis
in primary antiphospholipid syndrome neutrophils. Clin Immunol.
196:110–116. 2018.PubMed/NCBI View Article : Google Scholar
|
|
81
|
López-Pedrera C, Cerdó T, Jury EC,
Muñoz-Barrera L, Escudero-Contreras A, Aguirre MA and Pérez-Sánchez
C: New advances in genomics and epigenetics in antiphospholipid
syndrome. Rheumatology (Oxford). 63 (SI):SI14–SI23. 2024.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Caporossi L, Capanna S, Viganò P, Alteri A
and Papaleo B: From environmental to possible occupational exposure
to risk factors: What role do they play in the etiology of
endometriosis? Int J Environ Res Public Health.
18(532)2021.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Matta K, Lefebvre T, Vigneau E, Cariou V,
Marchand P, Guitton Y, Royer AL, Ploteau S, Le Bizec B, Antignac JP
and Cano-Sancho G: Associations between persistent organic
pollutants and endometriosis: A multiblock approach integrating
metabolic and cytokine profiling. Environ Int.
158(106926)2022.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Martirosyan A, Aminov R and Manukyan G:
Environmental triggers of autoreactive responses: Induction of
antiphospholipid antibody formation. Front Immunol.
10(1609)2019.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Oskotsky TT, Bhoja A, Bunis D, Le BL, Tang
AS, Kosti I, Li C, Houshdaran S, Sen S, Vallvé-Juanico J, et al:
Identifying therapeutic candidates for endometriosis through a
transcriptomics-based drug repositioning approach. iScience.
27(109388)2024.PubMed/NCBI View Article : Google Scholar
|
